Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planTo cover taxesNo plan disclosedOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 5 of the 13 calendar months from Oct 2025 to Oct 2026: Jan 2026, Mar 2026, May 2026, Aug 2026 and Sep 2026.
- Largest single sale: $9.8M (65,761 shares) of Protagonist Therapeutics, Inc on Aug 10, 2026. Filing
- Last sale before this period: Jul 25, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | President and CEO, Director | Aug 10, 2016 | Sep 10, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Sep 10, 2026, Protagonist Therapeutics, Inc: sold 7,278 shares for $1.0M, under a disclosed plan; 7,278 shares acquired by exercising options. 1 filing: 1
- Sep 9, 2026, Protagonist Therapeutics, Inc: sold 63,548 shares for $9.3M, under a disclosed plan; 63,548 shares acquired by exercising options. 1 filing: 1
- Sep 8, 2026, Protagonist Therapeutics, Inc: sold 54,174 shares for $7.9M, under a disclosed plan; 54,174 shares acquired by exercising options. 1 filing: 1
- Sep 3, 2026, Protagonist Therapeutics, Inc: 510 shares given away. 1 filing: 1
- Aug 11, 2026, Protagonist Therapeutics, Inc: sold 34,239 shares for $5.1M, under a disclosed plan; 34,239 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.